• Welcome to Kart Racing Pro Official Forum. Please login or sign up.
 
May 17, 2024, 04:25:50 AM

News:

Kart Racing Pro release13e available! :)


qbwi Metrion Biosciences, EU Partners Receive 鈧?.2M

Started by CharlesteWen, May 02, 2024, 12:24:07 PM

Previous topic - Next topic

CharlesteWen

Owpa My son did nothing wrong, claims Sharjeel s father
 ISLAMABAD:Technology neutral licence for the 10 MHz-850 MHz frequency spectrum has been handed over to the successful bidder - Telenor Pakistan - on Wednesday, making way for the company to become the third 4G operator in the country.Minister for IT and Telecommunication Anusha Rahman formally handed over 850 MHz licence to Telenor Pakistan CEO Michal Foley at a ceremony held at the IT Ministry, said a press release.Telenor Pakistan granted 4G  ugg hausschuhe licence for $395mRahman stated that Telenor had played a signifi stanley-cup cant role in the sector during the last few years and successfully participated in all three spectrum auctions held in the last twelve years.Rahman further said that when she became minister broadband penetration was less than 3 per cent but within a short span, mobile broadband had grown to more than 19% and is targeted to cross 38% by 2020. The new licence to Telenor will f adidas samba herren urther bring high speed connectivity and the associated socio economic benefits and opportunities to the Pakis Santaris Pharmaannounced that the DanishNational Advanced Technology Founda yeezy 500 tion (ATF) has awarded a grant of 鈧?.35 million towards the development of the first ever drug targeted against a human microRNA.The drug candidate, SPC3649, is an antagonist of the liver-specific microRNA-122 and is being developed by Santaris in collaboration with the Centre for Biological Sequence Analyses at theTechnical University of Denmark and the  nike store dunk Department of Cellular and Molecular Medicine, University of Copenhagen.This is the second award from the Danish ATF to the Santaris Pharma led consortium. In 2006 the ATF made a grant to Santaris and the University of Copenhagen of 鈧?.3m, to support research in the rapidly evolving field of microRNA therapeutics.Announcing the award, Sakari Kauppinen, Santaris Pharma鈥檚 Associate Director of MicroRNA Research, commented, "The entire field of molecular biology and medicine has been thrown wide open in recent years by the disc dunk nike low overy of microRNAs. Santaris Pharma鈥檚